首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
PembrolizumabMyasthenia gravis, myositis and myocarditis
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2024年
/ 2014卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-024-61983-6
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:555 / 555
相关论文
共 50 条
[21]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2017,
1658
(1)
: 373
-
373
[22]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2021,
1853
(1)
: 390
-
390
[23]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2019,
1764
(1)
: 268
-
268
[24]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2021,
1878
(1)
: 434
-
434
[25]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2024,
2029
(1)
: 545
-
545
[26]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2021,
1853
(1)
: 391
-
391
[27]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2020,
1828
(1)
: 414
-
414
[28]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2017,
1662
(1)
: 293
-
293
[29]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2017,
1650
(1)
: 226
-
226
[30]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2020,
1787
(1)
: 412
-
412
←
1
2
3
4
5
→